Varaico: Literature-Extracted Genetic Variants

Gene:MARVELD2
Variant:p.A444Splc
Back to variants list

MARVELD2

NM_001038603.3:p.A444Splc

Associated Papers

Bi-Allelic MARVELD2 Variant Identified with Exome Sequencing in a Consanguineous Multiplex Ghanaian Family Segregating Non-Syndromic Hearing Loss.

Twumasi Aboagye E et al.

International Journal of Molecular Sciences, 2025

Novel compound heterozygous variants in MARVELD2 causing autosomal recessive hearing loss in two Chinese families.

Shi X et al.

Molecular Genetics & Genomic Medicine, 2024

Investigation of Targeted Genes and Identification of Novel Variants with Next Generation Sequencing Method in Hearing Loss.

Zhuri D et al.

The Journal of International Advanced Otology, 2024

Genetic heterogeneity in hereditary hearing loss: Potential role of kinociliary protein TOGARAM2.

Ramzan M et al.

European Journal of Human Genetics : Ejhg, 2024

Autosomal recessive non-syndromic hearing loss genes in Pakistan during the previous three decades.

Shadab M et al.

Journal of Cellular and Molecular Medicine, 2024

Case report: A novel nonsense mutation in the MARVELD2 gene causes nonsyndromic hearing loss in a China family.

Huang C et al.

Frontiers in Genetics, 2024

Genetic Etiology of Nonsyndromic Hearing Loss in Hungarian Patients.

Pál M et al.

International Journal of Molecular Sciences, 2023

Molecular genetic landscape of hereditary hearing loss in Pakistan.

Naz S

Human Genetics, 2022

Genetic etiology of non-syndromic hearing loss in Europe.

Del Castillo I et al.

Human Genetics, 2022

Benefits of Exome Sequencing in Children with Suspected Isolated Hearing Loss.

Van Heurck R et al.

Genes, 2021

Variant c.2158-2A>G in MANBA is an important and frequent cause of hereditary hearing loss and beta-mannosidosis among the Czech and Slovak Roma population- evidence for a new ethnic-specific variant.

Safka Brozkova D et al.

Orphanet Journal of Rare Diseases, 2020

A Rare Mutation in the MARVELD2 Gene Can Cause Nonsyndromic Hearing Loss.

Sadeghi Z et al.

International Medical Case Reports Journal, 2020

A novel pathogenic variant in the MARVELD2 gene causes autosomal recessive non-syndromic hearing loss in an Iranian family.

Taghipour-Sheshdeh A et al.

Genomics, 2019

Molecular genetics of MARVELD2 and clinical phenotype in Pakistani and Slovak families segregating DFNB49 hearing loss.

Nayak G et al.

Human Genetics, 2015

MARVELD2 (DFNB49) mutations in the hearing impaired Central European Roma population--prevalence, clinical impact and the common origin.

Mašindová I et al.

Plos One, 2015

Comprehensive Analysis of Deafness Genes in Families with Autosomal Recessive Nonsyndromic Hearing Loss.

Atik T et al.

Plos One, 2015

DFNB49 is an important cause of non-syndromic deafness in Czech Roma patients but not in the general Czech population.

Šafka Brožková D et al.

Clinical Genetics, 2012

Autosomal recessive nonsyndromic deafness genes: a review.

Duman D et al.

Frontiers in Bioscience (landmark Edition), 2012

Splice-site mutations in the TRIC gene underlie autosomal recessive nonsyndromic hearing impairment in Pakistani families.

Chishti MS et al.

Journal of Human Genetics, 2008

Tricellulin is a tight-junction protein necessary for hearing.

Riazuddin S et al.

American Journal of Human Genetics, 2006

Diagnostic Yield of Targeted Hearing Loss Gene Panel Sequencing in a Large German Cohort With a Balanced Age Distribution from a Single Diagnostic Center: An Eight-year Study.

Tropitzsch A et al.

Ear and Hearing, 0

34753855 (PubMed )
Supplement: aud-43-1049-s003.xlsx › variant_1

Variability in Cochlear Implantation Outcomes in a Large German Cohort With a Genetic Etiology of Hearing Loss.

Tropitzsch A et al.

Ear and Hearing, 0

37438890 (PubMed )
Supplement: aud-44-1464-s001.pdf
Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."